Further studies on the response of the guinea-pig isolated bronchus to endothelins and SARAFOTOXIN S6B (cas 116303-65-2)
-
Add time:08/10/2019 Source:sciencedirect.com
Endothelin-1 (ET-1), endothelin-3 (ET-3) and sarafotoxin S6b (SRFTX) produced a concentration-dependent contraction of the guinea-pig isolated bronchus. In untreated preparations, SRFTX was about 10 times more potent than ET-1 or ET-3 and produced a greater maximal effect. Mechanical removal of the bronchial epithelium (rubbing) or the addition of indomethacin (5 μM) increased the potency of all peptides, ET-3 being enhanced more than ET-1 or SRFTX. Further, the activity of ET-3 was enhanced by a mixture of peptidase inhibitors (thiorphan, captopril, bestatin, 1 μM each). When the three potentiating factors were combined (rubbed bronchi in presence of indomethacin and peptidase inhibitors), the following order of potency was found, ET-3 ⋍ SRTFX >ET-1. For comparison, the activity of the three peptides was also studied in the rubbed rat isolated aorta in the presence of indomethacin and peptidase inhibitors and the following rank order of potency was found: ET-1 > SRFTX > ET-3. When the activity of the peptides was compared in these two preparations, ET-1 was 4 times more potent in the aorta than in the bronchus, while SRFTX and ET-3 were 8.7 and 133 times more potent in the bronchus than the aorta, respectively. These findings indicate that, in the guinea-pig bronchus, the contractile activity of these peptides is attenuated by the concomitant production of epithelium-derived relaxant factor(s), prostanoid production via the cyclooxygenase pathway and, possibly, enzymatic inactivation of added peptides. Further, the existence of multiple receptors mediating the contractile response to these peptides is suggested.
We also recommend Trading Suppliers and Manufacturers of SARAFOTOXIN S6B (cas 116303-65-2). Pls Click Website Link as below: cas 116303-65-2 suppliers
Prev:Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c
Next:The endothelin peptides ET-1, ET-2, ET-3 and SARAFOTOXIN S6B (cas 116303-65-2) are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The endothelin peptides ET-1, ET-2, ET-3 and SARAFOTOXIN S6B (cas 116303-65-2) are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells08/11/2019
- Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c08/09/2019
- Cardiac and vascular actions of SARAFOTOXIN S6B (cas 116303-65-2) and endothelin-108/08/2019
- Cardiac output effects of endothelin-1, -2 and -3 and SARAFOTOXIN S6B (cas 116303-65-2) in conscious rats08/07/2019
- Cardiovascular effects of two disulfide analogues of SARAFOTOXIN S6B (cas 116303-65-2)08/06/2019
- 1H NMR Study of the solution structure of sarafotoxin-S6b08/05/2019
- Cerebellar neurons and glia respond differentially to endothelins and SARAFOTOXIN S6B (cas 116303-65-2)08/04/2019
- Endothelin and SARAFOTOXIN S6B (cas 116303-65-2) have similar vasoconstrictor effects and postsynaptically mediated mechanisms08/03/2019
- Atypical receptors mediate the response to endothelin-1 and SARAFOTOXIN S6B (cas 116303-65-2) in the human umbilical artery08/02/2019